header
  Search CBBS Website


Strategies to minimize the use of pre-transfusion blood specimens that contain the wrong blood in the tube

A blood banker at a Florida hospital is considering putting centralized blood bank phlebotomy in place (i.e. phlebotomists that work out of the blood bank and draw all of the blood bank pre-transfusion samples for the hospital), as well as requiring a second separately collected blood sample for confirmation of ABO grouping for patients who have only a single current ABO result on file. She is aware of the discussions:

However, she would appreciate knowing which institutions currently employ either of the aforementioned practices.


The following comments have been received.

ADDENDA Nov. 24, 2007

1. A Transfusion Service Medical Director reports that at his teaching hospital in the Metropolitan Boston area a "Failure Mode Effect Analysis" group recently met to discuss strategies to minimize the use of pre-transfusion blood specimens that contain the wrong blood in the tube. He has graciously provided a synopsis of their policies:

  • Should pre-transfusion ABO/Rh testing be performed twice, and if so, on different samples or by different personnel? In the absence of a historical ABO/Rh record to compare against a current sample's ABO/Rh result, they will confirm the ABO/Rh by testing a sample in another section of the lab, provided that the second sample was drawn at a separate time. Otherwise, their LIS reflexs a request for a second sample to be collected from the patient. Pre-Admission samples that were submitted for type and screen only are not tested again on the day of surgery unless an antibody is identified, or blood for crossmatch is actually requested. They use a blood bank wristband and the band number is required on the cross-match tube, but not on the confirmatory tube (the "ditto tube"). It doesn't matter if the same tech does the retype, but it must be a on separately drawn tube.

  • Preventing pre-transfusion specimen labeling errors Specimens must be labeled at the bedside. A former lab director pronounced the "six foot" rule to label the specimen within six feet of the patient. The Blood Bank Band is initially applied at the time of collection. Their original blood bank bands had a unique number with corresponding numbered adhesive stickers to be affixed to the tube, but they found some mismatches. They recently switched to a band without stickers, so the phlebotomists have to write the number on the tube. Legibility has not yet been a problem.

  • Who should draw blood specimens for compatibility testing? They have a limited phlebotomy staff, so many tubes are drawn by nurses, housestaff, medical students and other paraprofessionals. They require that anyone drawing specimens for blood bank must undergo a competency training and evaluation, though a discussion ensued that there should be a universal standard competency for all phlebotomy specimens. The Medical Students were of particular concern, because they change over so frequently, with such brief stays, that it would difficult to ensure their evaluation and competence. Thus, Medical Students are not privileged to draw cross-match tubes. A second point is that the phlebotomist must be clearly identified by a legible entry on the tube of first initial and last name (or an employee number.) The Blood Bank really doesn't have the ability to screen for those with Blood Bank drawing privileges per se, but must have the ability to identify who drew the blood. The policy also calls for disciplinary action and a re-education plan for any staff member responsible for a mislabeling event. Furthermore, if the ditto tube is in error, e.g. a Hematology specimen, this needs to be corrected. The responding colleague adds that he has recently heard of some hospitals with a policy to have two people sign a phebotomy tube to ensure patient identification, but they rejected this policy. Finally, he suggests that colleagues refer to the CAP Standard TRM.30575 requiring a plan to implement a system to reduce the risk of mistransfusion for non-emergent red cell transfusions.The link to this newly revised Standard, including changes from previous is HERE (MS Word File).

Please submit comments to the e-Network Forum.

Ira A. Shulman, MD
CBBS e-Network Forum Editor & Moderator

W. Tait Stevens, MD
CBBS e-Network Forum Assistant Editor & Moderator

Printable PDF of this page


Posted: November 22, 2007

Addenda: Nov. 24, 2007

The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.